Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales Read more about Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management Read more about Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference Read more about Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference Read more about Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 Read more about Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth Read more about Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences Read more about Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 Read more about Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
